Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11

Current Opinion in Psychiatry

Volumn 30, Issue 4, 2017, Pages 227-237

  Saunders, John B ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

classification; diagnosis; gambling disorder; gaming disorder; substance dependence; substance use disorder; taxonomy

Indexed keywords

COMPARATIVE STUDY; DIAGNOSTIC TEST; DRUG DEPENDENCE; DRUG USE; DSM-5; GAME ADDICTION; HEALTH HAZARD; HUMAN; ICD-10; ICD-11; INTERMETHOD COMPARISON; MENTAL DISEASE; PATHOLOGICAL GAMBLING; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUBSTANCE USE; ADDICTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; IMPULSE CONTROL DISORDER; INTERNATIONAL CLASSIFICATION OF DISEASES; RESEARCH;

BEHAVIOR, ADDICTIVE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISRUPTIVE, IMPULSE CONTROL, AND CONDUCT DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; RESEARCH; SUBSTANCE-RELATED DISORDERS;

EID: 85020446851     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000332     Document Type: Review

References (37)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
3. World Health Organization. ICD 11 beta draft. Geneva: World Health Organization; 2016. http://apps.who.int/classifications/icd11/browse/l-m/en#.
4. World Health Organization. The ICD 10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
5. World Health Organization. The ICD 10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993. ISBN: 92-4-154455-4.
6. Saunders JB. Substance dependence and nondependence in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases (ICD): can an identical conceptualization be achieved? Addiction 2006; 101s1:48-58.
7. Edwards G, Gross MM. Alcohol dependence: provisional description of a clinical syndrome. Br Med J 1976; 1:1058-1061.
8. Edwards G, Arif A, Hodgson R. Nomenclature and classification of drug and alcohol-related problems: a WHO memorandum. Bull World Health Org 1981; 59:225-242.
9. Saha TD, Compton EM, Chou SP, et al. Analyses related to the development of DSM-5 criteria for substance use related disorders. Drug Alcohol Depend 2012; 122:38-46.
10. Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013; 170:834-851.
11. Hasin DS. Combining abuse and dependence in DSM-5. J Stud Alcohol Drugs 2012; 73:702-704.
12. Eng MY, Schuckit MA, Smith TL. A five-year prospective study of diagnostic orphans for alcohol use disorders. J Stud Alcohol 2003; 64:227-234.
13. Lago L, Bruno R, Degenhardt L. Concordance of ICD 11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey. Lancet Psychiatry 2016; 3:673-684.
14. Hasin DS, Kerridge BT, Saha TD, et al. Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry 2016; 173:588-599.
15. Compton WM, Baler R. The epidemiology of DSM-5 cannabis use disorders among U.S. adults: science to inform clinicians working in a shifting social landscape. Am J Psychiatry 2016; 173:551-553.
16. Saunders JB. Rationale for changes in the clinical descriptions and diagnostic guidelines of disorders due to substance use and related conditions in the draft ICD 11. Presented at the World Congress of the World Psychiatric Association, Madrid, Spain, September 2014. Available through the Department of Mental Health and Substance Abuse, WHO Geneva.
17. Poznyak V. An update on ICD-11 taxonomy of disorders due to psychoactive substance use and related health conditions. Presented at the WHO-ISBRA Symposium on Alcohol and Drug Diagnoses in the International Classification of Diseases, ISBRA-ESBRA Joint Congress, Berlin, Germany, September 2016. Available through the Department of Mental Health and Substance Abuse, WHO, Geneva.
18. Cottler LB, Hu H, Smallwood BA, et al. Nonmedical opioid pain relievers and all-cause mortality: a 27-year follow-up from the Epidemiologic Catchment Area Study. Am J Public Health 2016; 106:509-516.
19. O'Brien CP, Volkow N, Li T-K. What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry 2006; 163:764-765.
20. Degenhardt L, Bruno R, Lintzeris N, et al. Agreement between definitions of pharmaceutical opioid use disorders and dependence in people talking opioids for chronic noncancer (POINT) study. Lancet Psychiatry 2015; 2:314-322.
21. Rehm J, Room R, Graham K, et al. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 2003; 98:1209-1228.
22. Roerecke N, Rehm J. Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction 2013; 108:1562-1578.
23. Khan SR, Cottler LB, Striley CW. Correlates of use of alcohol mixed with energy drinks among youth across 10 US metropolitan areas. Drug Alcohol Dependence 2016; 163:236-241.
24. Saunders JB, Conigrave KM, Latt NC, et al., eds. Addiction medicine. 2nd ed. Oxford: Oxford University Press; 2016. ISBN:978-0-19-871475-0.
25. Mann K, Fauth-Bühler M, Higuchi S, et al. Pathological gambling: a behavioral addiction. World Psychiatry 2016; 15:297-298.
26. Petry NM, Rehbein F, Gentile DA, et al. An international consensus for assessing Internet Gaming Disorder using the new DSM-5 approach. Addiction 2014; 109:1399-1406.
27. King D, Delfabbro PH, Zwaans T, et al. Clinical features and Axis I comorbidity of Australian adolescent pathological internet and video game users. Aust NZ J Psychiatry 2013; 47:1058-1067.
28. Mihara S, Higuchi S. Cross-sectional and longitudinal epidemiological studies of internet gaming disorder: a systematic review of the literature. Psychiatry Clin Neurosci 2017. [in press]
29. Saunders JB, Hao W, Long J, et al. Gaming disorder: its delineation as an important condition for diagnosis, management and prevention. J Behav Addic 2017. [in press]
30. Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 2005; 18:249-255.
31. Volkow ND, Koob GF, McLellan T. Neurobiologic advances from the brain disease model of addiction. N Eng J Med 2016; 374:363-371.
32. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacol 2010; 35:217-238.
33. Kwako LE, Momenan R, Litten RZ, et al. Addictions Neuroclinical Assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry 2016; 80:179-189.
34. Ghitza UE. ASPIRE model for treating cannabis and other substance use disorders: a novel personalized medicine framework. Front Psychiatry 2014; 5:180.
35. Volkow ND, Koob GF, Baler R. Biomarkers of substance use disorders. ACS Chem Neurosci 2015; 6:522-525.
36. Kosak MJ, Cuthbert BN. The NIMH Research Domain Criteria initiative: background issues and pragmatics. Psychophysiology 2016; 53:286-297.
37. National Institute of Mental Health. Research Domain Criteria; 2016 www.nimh.nih.gov/research-priorities/rdoc/index.shtml